Advertisement
QIAGEN Ingenuity
QIAGEN Ingenuity

Most Recent

image: A Good Night’s Sleep

A Good Night’s Sleep

By | September 1, 2012

Sleep-wake cycles affect how well our bodies fight disease.

0 Comments

image: A Story Biological

A Story Biological

By | September 1, 2012

Using scientific information as narrative can be a powerful way to communicate.

0 Comments

image: Enter the Third Dimension

Enter the Third Dimension

By | September 1, 2012

Cell culture goes 3-D with devices that better mimic in vivo conditions.

2 Comments

image: Of Frogs and Embryos

Of Frogs and Embryos

By | September 1, 2012

Associate Professor in Molecular Cell & Developmental Biology at the University of Texas at Austin, John Wallingford, makes his living using cutting-edge microscopic techniques to watch developmental events unfold in real time.

4 Comments

image: Pleasant to the Touch

Pleasant to the Touch

By | September 1, 2012

Scientists hope an understanding of nerve fibers responsive only to gentle touch will give insight into the role the sense plays in social bonding.

0 Comments

image: Opinion: Younger Is Better

Opinion: Younger Is Better

By | August 31, 2012

Stem cells collected from younger donors are more effective for transplantation and regenerative medicine than those from older individuals.

9 Comments

image: The Danger of Vaccine Exemptions

The Danger of Vaccine Exemptions

By | August 30, 2012

Are states with less rigorous rules about which children can claim an exception from vaccination in kindergarten putting communities at higher risk of childhood disease?

4 Comments

image: Dieting Monkeys Don't Live Longer

Dieting Monkeys Don't Live Longer

By | August 29, 2012

The latest news from a long-term study of calorie restriction in rhesus macaques shows better health, but no boost in lifespan, in monkeys who eat less.

11 Comments

image: Epigenetic Drug Improves Cholesterol Levels

Epigenetic Drug Improves Cholesterol Levels

By | August 28, 2012

Results from a Phase II trial for cardiovascular disease with an epigenetic target therapy show promise.

1 Comment

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

Popular Now

  1. First Data from Anti-Aging Gene Therapy
  2. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

  3. The Zombie Literature
    Features The Zombie Literature

    Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?

  4. Locating Language within the Brain
Advertisement
Advertisement
RayBioTech